# Lumos Diagnostics receives initial orders for CoviDx in Canada

Lumos Diagnostics received initial orders worth approximately US$250,000 for its CoviDx SARS-CoV-2 rapid antigen test in Canada, expected to ship in December 2021.

- Type: Contract
- Announced: 2021-12-20
- Where: Canada
- Value: $250K
- Status: completed
- Products: CoviDx SARS-CoV-2 rapid antigen test
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lumos Diagnostics](https://endata.com/companies/59809.md)

## Sources

- [listcorp.com](https://www.listcorp.com/asx/ldx/lumos-diagnostics-holdings-limited/news/lumos-receives-initial-orders-for-covidx-in-canada-2649509.html), 2021-12-19: "We are pleased with these initial commercial orders for CoviDx so soon after receiving our Interim Order authorisation from Health Canada."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.